NCT02989870 2020-06-05Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular CarcinomaH. Lee Moffitt Cancer Center and Research InstitutePhase 1 Withdrawn
NCT01618253 2013-09-05Radiation Therapy With Sorafenib for TACE-Resistant Hepatocellular CarcinomaMedical College of WisconsinPhase 1 Withdrawn